Pasquale Bisceglia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pasquale Bisceglia has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aurelio Portincasa
Complex Unit of Plastic and Reconstructive Surgery, Department of Clinical and Experimental Medicine, Medical School, University of Foggia, 71100 Foggia, Italy
1 shared publication - Fabrizia Fusco
Pathology Unit, Policlinico Foggia, University of Foggia, 71122 Foggia, Italy
1 shared publication - Francesca Sanguedolce
Department of Pathology, University of Foggia, 71122 Foggia, Italy
1 shared publication - Francesco Drago
Casa di Cura Villa Montallegro, 16145 Genoa, Italy
1 shared publication - Gaetano Serviddio
Department of Medical and Surgical Sciences, University of Foggia, Viale Luigi Pinto 1, 71122 Foggia, Italy
1 shared publication - Giulia Ciccarese
Section of Dermatology, Department of Precision and Regenerative Medicine and Jonian Area University of Bari “Aldo Moro” Bari Italy
1 shared publication
Latest Publications
- Open Access
- 19 March 2026
- Published by MDPI AG in Microbiology Research
- Vol. 17 (3) , 61
Dermatofibrosarcoma Protuberans in a Patient Living with Human Immunodeficiency Virus Infection
Dermatofibrosarcoma protuberans (DFSP) is a rare tumor presenting as a slow-growing, plaque-like or multinodular, brownish lesion on the trunk in adult patients. Diagnosis is established by histological examination and surgical excision is the primary treatment. Typically, DFSP has an indolent course and local spread. In the present work, we describe the clinical–histologic features, surgical treatment and follow-up of a case of DFSP in a patient living with HIV infection (PLWH). A 40-year-old man was referred to us with confluent lesions on the left shoulder, present for about 3 years. His medical history was positive for HIV-1 infection, for which he was taking antiretroviral therapy. Microscopic examination showed dermal and hypodermic proliferation of spindle cells in a storiform pattern, confirming the clinical diagnosis of DFSP. A wide excision was performed with 3 cm clinically healthy tissue margins, and the defect was repaired using an artificial bilaminar dermal matrix. The histological examination revealed tumor-free margins, and a split-thickness skin graft was harvested from the same arm. After 10 months, the patient was free from the disease. As observed with other skin cancers, DFSP may have a higher incidence and greater aggressiveness in immunosuppressed than in immunocompetent patients. DFSP has been reported only twice in PLWH. Our case constitutes a third report, adding to the evidence that there may be an over-representation of this cancer in immunosuppressed individuals.
- 19 March 2026
- Published by MDPI AG in Microbiology Research
- Vol. 17 (3) , 61
Open AccessDermatofibrosarcoma Protuberans in a Patient Living with Human Immunodeficiency Virus Infection
Dermatofibrosarcoma protuberans (DFSP) is a rare tumor presenting as a slow-growing, plaque-like or multinodular, brownish lesion on the trunk in adult patients. Diagnosis is established by histological examination and surgical excision is the primary treatment. Typically, DFSP has an indolent course and local spread. In the present work, we describe the clinical–histologic features, surgical treatment and follow-up of a case of DFSP in a patient living with HIV infection (PLWH). A 40-year-old man was referred to us with confluent lesions on the left shoulder, present for about 3 years. His medical history was positive for HIV-1 infection, for which he was taking antiretroviral therapy. Microscopic examination showed dermal and hypodermic proliferation of spindle cells in a storiform pattern, confirming the clinical diagnosis of DFSP. A wide excision was performed with 3 cm clinically healthy tissue margins, and the defect was repaired using an artificial bilaminar dermal matrix. The histological examination revealed tumor-free margins, and a split-thickness skin graft was harvested from the same arm. After 10 months, the patient was free from the disease. As observed with other skin cancers, DFSP may have a higher incidence and greater aggressiveness in immunosuppressed than in immunocompetent patients. DFSP has been reported only twice in PLWH. Our case constitutes a third report, adding to the evidence that there may be an over-representation of this cancer in immunosuppressed individuals.